Avive Solutions, Inc.

Industry
Medical Devices
Founded Year
2017
Headquarters
Brisbane, California
Employee Count
0

Key People

  • Sameer Jafri - CEO
  • Rory Beyer - Co-Founder
  • Moseley Andrews - Co-Founder

Assessment

Team
Aspect: First-time 10+ yrs
Summary: The founding team comprises individuals with over a decade of experience in the medical technology sector.

The leadership's background in medical technology enhances the company's credibility and operational effectiveness.

Clinical Need
Aspect: Very Strong
Summary: The product addresses a critical need in emergency cardiac care.

Sudden cardiac arrest is a leading cause of death; accessible defibrillation solutions are essential.

Competition
Aspect: Very crowded + Strategics
Summary: The market features numerous established players and strategic partnerships.

Dominant companies with extensive resources and partnerships create a competitive landscape.

Technical Challenge
Aspect: Predictable
Summary: The technology is well-understood with manageable development risks.

Existing knowledge in defibrillator technology reduces unforeseen obstacles.

Patent
Aspect: Strong
Summary: The company holds robust patents protecting its innovations.

Intellectual property rights safeguard the company's unique technologies from competitors.

Financing
Aspect: Well-funded
Summary: The company has secured substantial funding to support its operations.

Significant investments from reputable funds indicate confidence in the company's potential.

Regulatory
Aspect: 510k/PMA
Summary: The product has obtained necessary regulatory approvals.

Compliance with FDA standards demonstrates product safety and efficacy.

Opportunity Rollup

Odds of Success
4
Peak Market Share
5.55
Segment CAGR
9.7%
Market Segment
Medical Devices
Market Sub Segment
Automated External Defibrillators
Year Post Launch Market Penetration (%)
1 0.28
2 0.83
3 1.94
4 3.88
5 5.55

Key Takeaway

Avive Solutions, Inc. is well-positioned in the growing AED market, leveraging strong leadership, innovative technology, and substantial funding to address a critical clinical need amidst a competitive landscape.